Latest Industry News

All

VelaVigo's Bold Move: How Chinese-US Biotech Collaborations are Revolutionizing Antibody Discovery

VelaVigo’s Bold Move: How Chinese-US Biotech Collaborations are Revolutionizing Antibody Discovery

Eli Lilly's Orforglipron: A Game-Changer in the Fight Against Obesity and Diabetes with Promising Phase 3 Results

Eli Lilly’s Orforglipron: A Game-Changer in the Fight Against Obesity and Diabetes with Promising Phase 3 Results

Blenrep: New Hope for Multiple Myeloma Patients as GSK Secures First Worldwide Approval in the UK

Blenrep: New Hope for Multiple Myeloma Patients as GSK Secures First Worldwide Approval in the UK

Leadership Change at Charm Therapeutics: CEO Laksh Aithani Steps Down as Company Aims for AI-Driven Clinical Trials by 2026

Leadership Change at Charm Therapeutics: CEO Laksh Aithani Steps Down as Company Aims for AI-Driven Clinical Trials by 2026

Bluebird Bio Faces Turbulent Times as Takeover Bid from Ayrmid Falls Flat: What Investors Need to Know

Bluebird Bio Faces Turbulent Times as Takeover Bid from Ayrmid Falls Flat: What Investors Need to Know

Trump's New Drug Pricing Executive Order: A Mixed Bag for the Biopharma Industry

Trump’s New Drug Pricing Executive Order: A Mixed Bag for the Biopharma Industry

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

VelaVigo's Bold Move: How Chinese-US Biotech Collaborations are Revolutionizing Antibody Discovery

VelaVigo’s Bold Move: How Chinese-US Biotech Collaborations are Revolutionizing Antibody Discovery

Eli Lilly's Orforglipron: A Game-Changer in the Fight Against Obesity and Diabetes with Promising Phase 3 Results

Eli Lilly’s Orforglipron: A Game-Changer in the Fight Against Obesity and Diabetes with Promising Phase 3 Results

Blenrep: New Hope for Multiple Myeloma Patients as GSK Secures First Worldwide Approval in the UK

Blenrep: New Hope for Multiple Myeloma Patients as GSK Secures First Worldwide Approval in the UK

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA